ClinicalTrials.Veeva

Menu

Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study (RPRCT)

University of Virginia logo

University of Virginia

Status and phase

Not yet enrolling
Phase 4

Conditions

Interscalene Block
Shoulder Arthroplasty
Rebound Pain

Treatments

Drug: Bupivacaine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Randomized control study that compares different concentrations of local anesthetic to investigate whether a lower concentration of local anesthetic would contribute to lower rebound pain scores at 24 hours post op in patients undergoing anatomic or reverse total shoulder arthroplasty.

Enrollment

168 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Total shoulder replacement patients (anatomic and reverse)
  • Adult patients (greater than or equal to 18 years)
  • Any gender
  • Any race

Exclusion criteria

  • - Chronic Pain diagnoses including:
  • substance/opioid use disorder
  • complex regional pain syndromes
  • fibromyalgia
  • Daily persistent opioid use spanning 3 months prior to surgery date
  • Allergy to local anesthetics or NSAIDS
  • Respiratory pathologies including:
  • CPAP- non-compliant / untreated obstructive sleep apnea
  • COPD
  • Restrictive lung disease (pulmonary fibrosis, interstitial pneumonia, etc)
  • Contralateral diaphragm dysfunction
  • BMI > 40
  • Ipsilateral extremity pre-existing nerve injury
  • GFR < 60
  • NSAID contraindications
  • Inability to follow up
  • Revision surgery
  • Patients requesting block as primary (avoidance of general anesthesia)
  • Need or request for brachial plexus catheter or liposomal bupivacaine
  • Vulnerable populations (pregnancy, incarceration, etc)
  • non-English speaking

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

168 participants in 2 patient groups

Concentrated
Active Comparator group
Description:
Standard management of higher percent local anesthetic: 0.5% Bupivacaine
Treatment:
Drug: Bupivacaine
Dilute
Experimental group
Description:
More dilute local : 0.25% Bupivacaine
Treatment:
Drug: Bupivacaine

Trial contacts and locations

1

Loading...

Central trial contact

Brett Elmore, MD; Leon N Grinman, DO

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems